Directors John Covert and Gaby Longsworth, Ph.D. presented the webinar “Patent Term Extension Considerations for BioPharma Patents,” which covered the interplay between PTE, Patent Term Adjustment (PTA), and obviousness-type double patenting (ODP) as well as strategies for choosing a patent to extend; managing multiple PTE requests; the pitfalls of interim extensions; and the provisions and responsibilities of the USPTO and FDA. Read our webinar Q&A highlights and watch the On-Demand recording to learn more about the intricacies of patent term extension procedures and strategy in the life sciences industry, and how an extended patent relates to overall exclusivity. #PTE #biopharma
